Request for Covid-19 Impact Assessment of this Report
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global RNA Next-Generation Sequencing market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global RNA Next-Generation Sequencing market segmented into
Enrichment Approaches
Amplicon-Based Approaches
Based on the end-use, the global RNA Next-Generation Sequencing market classified into
Research Institutes
Hospitals and Clinics
Biotechnology Company
Diagnostic Lab
Based on geography, the global RNA Next-Generation Sequencing market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Roche
Illumina
Thermo Fisher Scientific
Beckman Coulter
Abbott Molecular
Pacific Biosciences
Oxford Nanopore Technologies
Eurofins Scientific
Macrogen
GENEWIZ
BGI
Berry Genomics
QIAGEN
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL RNA NEXT-GENERATION SEQUENCING INDUSTRY
2.1 Summary about RNA Next-Generation Sequencing Industry
2.2 RNA Next-Generation Sequencing Market Trends
2.2.1 RNA Next-Generation Sequencing Production & Consumption Trends
2.2.2 RNA Next-Generation Sequencing Demand Structure Trends
2.3 RNA Next-Generation Sequencing Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Enrichment Approaches
4.2.2 Amplicon-Based Approaches
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Research Institutes
4.3.2 Hospitals and Clinics
4.3.3 Biotechnology Company
4.3.4 Diagnostic Lab
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Enrichment Approaches
5.2.2 Amplicon-Based Approaches
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Research Institutes
5.3.2 Hospitals and Clinics
5.3.3 Biotechnology Company
5.3.4 Diagnostic Lab
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Enrichment Approaches
6.2.2 Amplicon-Based Approaches
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Research Institutes
6.3.2 Hospitals and Clinics
6.3.3 Biotechnology Company
6.3.4 Diagnostic Lab
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Enrichment Approaches
7.2.2 Amplicon-Based Approaches
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Research Institutes
7.3.2 Hospitals and Clinics
7.3.3 Biotechnology Company
7.3.4 Diagnostic Lab
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Enrichment Approaches
8.2.2 Amplicon-Based Approaches
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Research Institutes
8.3.2 Hospitals and Clinics
8.3.3 Biotechnology Company
8.3.4 Diagnostic Lab
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Enrichment Approaches
9.2.2 Amplicon-Based Approaches
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Research Institutes
9.3.2 Hospitals and Clinics
9.3.3 Biotechnology Company
9.3.4 Diagnostic Lab
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Roche
10.1.2 Illumina
10.1.3 Thermo Fisher Scientific
10.1.4 Beckman Coulter
10.1.5 Abbott Molecular
10.1.6 Pacific Biosciences
10.1.7 Oxford Nanopore Technologies
10.1.8 Eurofins Scientific
10.1.9 Macrogen
10.1.10 GENEWIZ
10.1.11 BGI
10.1.12 Berry Genomics
10.1.13 QIAGEN
10.2 RNA Next-Generation Sequencing Sales Date of Major Players (2017-2020e)
10.2.1 Roche
10.2.2 Illumina
10.2.3 Thermo Fisher Scientific
10.2.4 Beckman Coulter
10.2.5 Abbott Molecular
10.2.6 Pacific Biosciences
10.2.7 Oxford Nanopore Technologies
10.2.8 Eurofins Scientific
10.2.9 Macrogen
10.2.10 GENEWIZ
10.2.11 BGI
10.2.12 Berry Genomics
10.2.13 QIAGEN
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table RNA Next-Generation Sequencing Product Type Overview
2.Table RNA Next-Generation Sequencing Product Type Market Share List
3.Table RNA Next-Generation Sequencing Product Type of Major Players
4.Table Brief Introduction of Roche
5.Table Brief Introduction of Illumina
6.Table Brief Introduction of Thermo Fisher Scientific
7.Table Brief Introduction of Beckman Coulter
8.Table Brief Introduction of Abbott Molecular
9.Table Brief Introduction of Pacific Biosciences
10.Table Brief Introduction of Oxford Nanopore Technologies
11.Table Brief Introduction of Eurofins Scientific
12.Table Brief Introduction of Macrogen
13.Table Brief Introduction of GENEWIZ
14.Table Brief Introduction of BGI
15.Table Brief Introduction of Berry Genomics
16.Table Brief Introduction of QIAGEN
17.Table Products & Services of Roche
18.Table Products & Services of Illumina
19.Table Products & Services of Thermo Fisher Scientific
20.Table Products & Services of Beckman Coulter
21.Table Products & Services of Abbott Molecular
22.Table Products & Services of Pacific Biosciences
23.Table Products & Services of Oxford Nanopore Technologies
24.Table Products & Services of Eurofins Scientific
25.Table Products & Services of Macrogen
26.Table Products & Services of GENEWIZ
27.Table Products & Services of BGI
28.Table Products & Services of Berry Genomics
29.Table Products & Services of QIAGEN
30.Table Market Distribution of Major Players
31.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
32.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
33.Table Global RNA Next-Generation Sequencing Market Forecast (Million USD) by Region 2021f-2026f
34.Table Global RNA Next-Generation Sequencing Market Forecast (Million USD) Share by Region 2021f-2026f
35.Table Global RNA Next-Generation Sequencing Market Forecast (Million USD) by Demand 2021f-2026f
36.Table Global RNA Next-Generation Sequencing Market Forecast (Million USD) Share by Demand 2021f-2026f
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...